Literature DB >> 25549975

Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.

Małgorzata Mizerska-Wasiak1, Jadwiga Małdyk, Agnieszka Rybi-Szumińska, Anna Wasilewska, Monika Miklaszewska, Jacek Pietrzyk, Agnieszka Firszt-Adamczyk, Roman Stankiewicz, Beata Bieniaś, Małgorzata Zajączkowska, Katarzyna Gadomska-Prokop, Ryszard Grenda, Agnieszka Pukajło-Marczyk, Danuta Zwolińska, Maria Szczepańska, Agnieszka Turczyn, Maria Roszkowska-Blaim.   

Abstract

BACKGROUND: The aim of this study was to evaluate the usefulness of serum immunoglobulin A/complement factor 3 (IgA/C3) ratio for predicting histological severity of kidney lesions in children with IgA nephropathy (IgAN) based on World Health Organization (WHO) and the Oxford classification (OC).
METHODS: We studied 89 children with IgAN with a mean age of 11.38 ± 4.1 years (range 2-18 years). Based on available medical records, we retrospectively evaluated clinical data, IgA/C3 ratio, and kidney biopsy findings using the five-grade WHO classification and the OC The mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental sclerosis (S), tubular atrophy/interstitial fibrosis (T) (MEST) score (absent = 0, present = 1) calculated as the sum of M+E+S+T ranging from 0 to 4.
RESULTS: Mean IgA/C3 ratio values were significantly higher (P < 0.05) in patients with M1, S1, and T1 compared with M0, S0, and T0, respectively (P < 0.05); there were no differences in the WHO classification. We found a significant positive correlation between the IgA/C3 ratio and proteinuria (r = 0.24) and determined optimal cutoff values of the IgA/C3 ratio, with a corresponding confidence interval for specific MEST scores.
CONCLUSIONS: The IgA/C3 ratio in children with IgAN may be a useful marker of the severity of lesions found in kidney biopsy as evaluated using the OC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25549975     DOI: 10.1007/s00467-014-3024-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

Review 1.  IgA nephropathy in children.

Authors:  N Yoshikawa; K Iijima; H Ito
Journal:  Nephron       Date:  1999-09       Impact factor: 2.847

2.  Relationship between serum IgA/C3 ratio and progression of IgA nephropathy.

Authors:  Hiroyuki Komatsu; Shouichi Fujimoto; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Tanenao Eto
Journal:  Intern Med       Date:  2004-11       Impact factor: 1.271

3.  Relationship between the serum IgA/C3 ratio and the progression of IgA nephropathy.

Authors:  Yasuhiko Tomino
Journal:  Intern Med       Date:  2004-11       Impact factor: 1.271

4.  Nephelometry and turbidimetry with paired emitter detector diodes and their application for determination of total urinary protein.

Authors:  Kamil Strzelak; Robert Koncki
Journal:  Anal Chim Acta       Date:  2013-06-18       Impact factor: 6.558

5.  Repeat renal biopsy in children with IgA nephropathy.

Authors:  N Yoshikawa; K Iijima; S Matsuyama; J Suzuki; A Kameda; S Okada; H Nakamura
Journal:  Clin Nephrol       Date:  1990-04       Impact factor: 0.975

Review 6.  Pathophysiology and treatment of IgA nephropathy in children.

Authors:  N Yoshikawa; R Tanaka; K Iijima
Journal:  Pediatr Nephrol       Date:  2001-05       Impact factor: 3.714

7.  Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy.

Authors:  Y Tomino; S Suzuki; H Imai; T Saito; T Kawamura; N Yorioka; T Harada; Y Yasumoto; H Kida; Y Kobayashi; M Endoh; H Sato; K Saito
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

8.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

9.  Activation of the alternative pathway of complement by human serum IgA.

Authors:  P S Hiemstra; A Gorter; M E Stuurman; L A Van Es; M R Daha
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

10.  Comparison of clinicopathological features between children and adults with IgA nephropathy.

Authors:  Tianzhen Wang; Fei Ye; Hongxue Meng; Lei Zhang; Xiaoming Jin
Journal:  Pediatr Nephrol       Date:  2012-05-05       Impact factor: 3.714

View more
  11 in total

1.  C4d deposits in IgA nephropathy: where does complement activation come from?

Authors:  Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

2.  Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.

Authors:  Aliza Thompson; Kevin Carroll; Lesley A Inker; Jürgen Floege; Vlado Perkovic; Sonia Boyer-Suavet; Rupert W Major; Judith I Schimpf; Jonathan Barratt; Daniel C Cattran; Barbara S Gillespie; Annamaria Kausz; Alex W Mercer; Heather N Reich; Brad H Rovin; Melissa West; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-11       Impact factor: 8.237

3.  Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy.

Authors:  Pei Chen; Guizhen Yu; Xue Zhang; Xinfang Xie; Jinwei Wang; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-11       Impact factor: 8.237

4.  How to take advantage of easily available biomarkers in patients with IgA nephropathy: IgA and C3 in serum and kidney biopsies.

Authors:  Małgorzata Mizerska-Wasiak
Journal:  Pediatr Nephrol       Date:  2022-08-02       Impact factor: 3.651

5.  Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study.

Authors:  Min Pan; Ji Zhang; Zhanyuan Li; Lingwei Jin; Yu Zheng; Zhihong Zhou; Su Zhen; Guoyuan Lu
Journal:  BMC Nephrol       Date:  2017-07-11       Impact factor: 2.388

6.  A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.

Authors:  Jin Dong; Tianhao Peng; Jing Gao; Xingwang Jia; Guangtao Yan; Yong Wang
Journal:  BMC Immunol       Date:  2018-06-20       Impact factor: 3.615

7.  High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.

Authors:  Wen-Yu Gong; Man Liu; Dan Luo; Fan-Na Liu; Liang-Hong Yin; Yuan-Qing Li; Jun Zhang; Hui Peng
Journal:  BMC Nephrol       Date:  2019-04-30       Impact factor: 2.388

8.  Serum IgA/C3 ratio and glomerular C3 staining predict progression of IgA nephropathy in children.

Authors:  Yuanyuan Lang; Shaona Song; Linsheng Zhao; Yi Yang; Tao Liu; Yongming Shen; Wenhong Wang
Journal:  Transl Pediatr       Date:  2021-03

Review 9.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561

Review 10.  The Role of Immune Modulation in Pathogenesis of IgA Nephropathy.

Authors:  Sheng Chang; Xiao-Kang Li
Journal:  Front Med (Lausanne)       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.